Ning, S., Ma, S., Saleh, A. Q., Guo, L., Zhao, Z., & Chen, Y. (2018). SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma. Gastroenterol Res Pract.
Chicago Style CitationNing, Shanglei, Siquan Ma, Abdul Qahar Saleh, Lingyu Guo, Zixiao Zhao, i Yuxin Chen. "SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma." Gastroenterol Res Pract 2018.
Cita MLANing, Shanglei, et al. "SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma." Gastroenterol Res Pract 2018.
Atenció: Aquestes cites poden no estar 100% correctes.